Below are the financial statements of ADMA Biologics, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in millions of USD | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenues | 426.45a | 258.22a | 154.08a |
| Cost of product revenue | -206.9a | -169.27a | -118.82a |
| Gross profit | 219.55a | 88.94a | 35.27a |
| Operating expenses | — | — | — |
| Research and development | -1.81a | -3.3a | -3.61a |
| Plasma center operating expenses | -4.25a | -4.27a | -17.84a |
| Amortization of intangible assets | -0.39a | -0.72a | -0.72a |
| Selling, general and administrative | -74.12a | -59.02a | -52.46a |
| Total operating expenses | -80.57a | -67.31a | -74.63a |
| Income (loss) from operations | 138.98a | 21.63a | -39.37a |
| Other income (expense) | — | — | — |
| Interest income | 2.1a | 1.62a | 0.05a |
| Interest expense | -13.93a | -25.03a | -19.28a |
| Loss on extinguishment of debt | -1.24a | -26.17a | -6.67a |
| Other expense | -0.19a | -0.29a | -0.64a |
| Other expense, net | -13.27a | -49.87a | -26.54a |
| Income (loss) before income taxes | 125.71a | -28.24a | -65.9a |
| Income tax benefit | -71.96a | 0a | 0a |
| Net income (loss) | 197.67a | -28.24a | -65.9a |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore ADMA Biologics’s data sources below and access millions more through our Disclosure Search.
Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.